Average Insider

Where insiders trade, we follow

Alpha Cognition Inc.

๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
$ACOG
Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer's disease and mild traumatic brain injury. It also develops ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases. The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021. Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.
Financial Services
Sector
Financial - Conglomerates
Industry
Michael E. McFadden
CEO
5
Employees
$5.59
Current Price
$72.49M
Market Cap
52W Low$3.75
Current$5.5923.6% above low, 76.4% below high
52W High$11.54

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys11$11,950.462,094All Buys
Sells00--
2 weeksBuys15$109,612.3418,972All Buys
Sells00--
1 monthBuys117$1,297,796.96224,099All Buys
Sells00--
2 monthsBuys121$1,961,904.02336,918All Buys
Sells00--
3 monthsBuys121$1,961,904.02336,918All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Mar 18, 2026
Opaleye Management Inc.
10% Owner
Purchase2,481$5.75$14,263.27View Details
Mar 19, 2026
Opaleye Management Inc.
10% Owner
Purchase2,094$5.71$11,950.46View Details
Mar 16, 2026
Opaleye Management Inc.
10% Owner
Purchase1,331$5.78$7,695.84View Details
Mar 12, 2026
Opaleye Management Inc.
10% Owner
Purchase5,708$5.85$33,416.34View Details
Mar 13, 2026
Opaleye Management Inc.
10% Owner
Purchase7,358$5.75$42,286.43View Details
Mar 9, 2026
Opaleye Management Inc.
10% Owner
Purchase2,179$5.85$12,742.14View Details
Mar 6, 2026
Opaleye Management Inc.
10% Owner
Purchase1,900$5.80$11,017.91View Details
Mar 4, 2026
Opaleye Management Inc.
10% Owner
Purchase19,795$5.81$115,001.03View Details
Mar 5, 2026
Opaleye Management Inc.
10% Owner
Purchase42,023$5.80$243,632.54View Details
Mar 5, 2026
Opaleye Management Inc.
10% Owner
Purchase5,000$5.80$28,988.00View Details
Mar 2, 2026
Opaleye Management Inc.
10% Owner
Purchase20,000$5.80$116,000.00View Details
Mar 3, 2026
Opaleye Management Inc.
10% Owner
Purchase46,411$5.75$266,872.53View Details
Mar 3, 2026
Opaleye Management Inc.
10% Owner
Purchase5,000$5.75$28,751.00View Details
Feb 26, 2026
Opaleye Management Inc.
10% Owner
Purchase590$5.99$3,531.15View Details
Feb 27, 2026
Opaleye Management Inc.
10% Owner
Purchase3,638$5.99$21,797.08View Details
Feb 24, 2026
Opaleye Management Inc.
10% Owner
Purchase5,000$5.80$29,002.00View Details
Feb 23, 2026
Opaleye Management Inc.
10% Owner
Purchase95,819$5.89$564,594.29View Details
Feb 20, 2026
Opaleye Management Inc.
10% Owner
Purchase2,819$5.84$16,466.06View Details
Feb 20, 2026
Opaleye Management Inc.
10% Owner
Purchase10,000$5.84$58,411.00View Details
Feb 24, 2026
Opaleye Management Inc.
10% Owner
Purchase53,591$5.80$310,849.24View Details

Upcoming Earnings

Scheduled earnings reports
Mar 26, 2026
EPS
Estimated-$0.27
ActualN/A
Revenue
Estimated$4.40M
ActualN/A
Mar 30, 2026
EPS
Estimated-$0.27
ActualN/A
Revenue
Estimated$4.40M
ActualN/A

Past Earnings

Historical earnings results
No past earnings data available

Related Activity

Cross-company insider connections and cluster buy signals

Insiders Also Active At

Insiders at this company also hold positions or have traded at these companies:

$CDXS โ€” CODEXIS, INC.via Opaleye Management Inc.$SNWV โ€” SANUWAVE Health, Inc.via Opaleye Management Inc.$SLGL โ€” Sol-Gel Technologies Ltd.via Opaleye Management Inc.$ETON โ€” Eton Pharmaceuticals, Inc.via Opaleye Management Inc.
Version: v26.3.29